EIF4A1 and central nervous system cancer: In agreement with this finding, our analysis shows that EIF4A1 and EIF4A3 are significantly increased in gliomas including GBM for the four subtypes compared to non-cancerous brain tissue whereas EIF4A2 expression is significantly downregulated (Table 1).